Literature DB >> 21484928

Molecular diagnosis of dermatofibrosarcoma protuberans: a comparison between reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization methodologies.

Rocío Salgado1, Beatriz Llombart, Ramon M Pujol, Antonio Fernández-Serra, Onofre Sanmartín, Agustí Toll, Luis Rubio, Sonia Segura, Carlos Barranco, Carlos Serra-Guillén, Mireia Yébenes, Marta Salido, Víctor Traves, Carlos Monteagudo, Empar Sáez, Teresa Hernández, Enrique de Álava, Antonio Llombart-Bosch, Francesc Solé, Carlos Guillén, Blanca Espinet, Jose A López-Guerrero.   

Abstract

Dermatofibrosarcoma protuberans (DFSP) is characterized by the presence of the t(17;22)(q22;q13) that leads to the fusion of the COL1A1 and PDGFB genes. This translocation can be detected by multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) or fluorescence in situ hybridization (FISH) techniques. We have evaluated the usefulness of a dual color dual fusion FISH probe strategy for COL1A1/PDGFB detection in a series of 103 archival DFSPs and compared the obtained results with RT-PCR analyses. FISH and RT-PCR were carried out on paraffin embedded tissue samples. Regarding the RT-PCR approach, all COL1A1 exons and exon 2 of PDGFB were evaluated. Sensitivity, specificity, positive and negative predictive values were assessed considering the histological diagnosis as the gold standard. We also analyzed the relationship between the genetic findings and the clinicopathological variables of the tumors. The COL1A1/PDGFB translocation was detected in 93% of DFSP. Both techniques showed a similar specificity (100%), but FISH was more sensitive than RT-PCR (90% vs. 72%). Regarding, clinicopathological features, a higher percentage of positive cells detected by FISH was significantly associated with the fibrosarcomatous DFSP variant (P < 0.001). Interestingly, all CD34 negative DFSP (n = 5) were positive for COL1A1/PDGFB translocation by both techniques. In conclusion, the majority of DFSP harbor the COL1A1/PDGFB translocation and FISH technique should be recommended as a routine diagnostic tool, especially in cases showing unusual histopathological subtypes and/or immunohistochemical features.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21484928     DOI: 10.1002/gcc.20874

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  12 in total

1.  PDGFB Rearrangements in Dermatofibrosarcoma Protuberans of the Vulva: A Study of 11 Cases Including Myxoid and Fibrosarcomatous Variants.

Authors:  Khadijeh Jahanseir; Deyin Xing; Patricia T Greipp; William R Sukov; Gary L Keeney; Brooke E Howitt; J Kenneth Schoolmeester
Journal:  Int J Gynecol Pathol       Date:  2018-11       Impact factor: 2.762

Review 2.  Regorafenib for the Treatment of Sarcoma.

Authors:  Jean-Yves Blay; Florence Duffaud; Suzanne George; Robert G Maki; Nicolas Penel
Journal:  Curr Treat Options Oncol       Date:  2022-09-30

3.  Dermatofibrosarcoma protuberans in a 10-year-old child.

Authors:  Uwe Wollina
Journal:  J Dermatol Case Rep       Date:  2013-12-30

Review 4.  Molecular strategies for detecting chromosomal translocations in soft tissue tumors (review).

Authors:  Margherita Cerrone; Monica Cantile; Francesca Collina; Laura Marra; Giuseppina Liguori; Renato Franco; Annarosaria De Chiara; Gerardo Botti
Journal:  Int J Mol Med       Date:  2014-04-04       Impact factor: 4.101

Review 5.  Use of Fluorescence In Situ Hybridization (FISH) in Diagnosis and Tailored Therapies in Solid Tumors.

Authors:  Natalia Magdalena Chrzanowska; Janusz Kowalewski; Marzena Anna Lewandowska
Journal:  Molecules       Date:  2020-04-17       Impact factor: 4.411

6.  Molecular characterization and clinical impact of TMPRSS2-ERG rearrangement on prostate cancer: comparison between FISH and RT-PCR.

Authors:  A Fernández-Serra; L Rubio; A Calatrava; J Rubio-Briones; R Salgado; R Gil-Benso; B Espinet; Z García-Casado; J A López-Guerrero
Journal:  Biomed Res Int       Date:  2013-05-28       Impact factor: 3.411

7.  Cytogenetics and molecular genetics of myxoid soft-tissue sarcomas.

Authors:  Jun Nishio; Hiroshi Iwasaki; Kazuki Nabeshima; Masatoshi Naito
Journal:  Genet Res Int       Date:  2011-07-28

Review 8.  Dermatofibrosarcoma protuberans: from translocation to targeted therapy.

Authors:  Jonathan Noujaim; Khin Thway; Cyril Fisher; Robin L Jones
Journal:  Cancer Biol Med       Date:  2015-12       Impact factor: 4.248

9.  Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases.

Authors:  Giuliana Cassinelli; Enrica Favini; Laura Dal Bo; Monica Tortoreto; Marcella De Maglie; Gianpaolo Dagrada; Silvana Pilotti; Franco Zunino; Nadia Zaffaroni; Cinzia Lanzi
Journal:  Oncotarget       Date:  2016-07-26

Review 10.  Association between TMPRSS2:ERG fusion gene and the prostate cancer: systematic review and meta-analysis.

Authors:  Herney Andrés García-Perdomo; Maria Juliana Chaves; Julio Cesar Osorio; Adalberto Sanchez
Journal:  Cent European J Urol       Date:  2018-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.